WallStreetZenWallStreetZen

NASDAQ: CLRB
Cellectar Biosciences Inc Stock Ownership - Who owns Cellectar Biosciences?

Insider buying vs selling

Have Cellectar Biosciences Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CLRB insiders and whales buy or sell their stock.

CLRB Shareholders

What type of owners hold Cellectar Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Rosalind Advisors Inc16.32%2,005,658$7.72MInstitution
Aigh Capital Management LLC15.59%1,915,220$7.37MInstitution
Adar1 Capital Management LLC11.21%1,378,082$5.31MInstitution
Nantahala Capital Management LLC10.99%1,350,578$5.20MInstitution
Austin W. Greenhouse David M. Marxe9.30%1,142,368$4.40MInsider
John Neis8.05%989,818$3.81MInsider
Worth Venture Partners LLC5.65%693,909$2.67MInstitution
Cormorant Asset Management LP4.31%530,000$2.04MInsider
Vanguard Group Inc3.93%482,890$1.86MInstitution
Acuta Capital Partners LLC3.89%477,500$1.84MInstitution

1 of 3

CLRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLRB26.67%12.70%
IMUX16.47%17.18%Net BuyingNet Buying
MCRB59.28%30.14%Net SellingNet Selling
VIGL44.03%55.97%Net Buying
PDSB26.78%37.69%

Cellectar Biosciences Stock Ownership FAQ

Who owns Cellectar Biosciences?

Cellectar Biosciences (NASDAQ: CLRB) is owned by 26.67% institutional shareholders, 12.70% Cellectar Biosciences insiders, and 60.63% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Cellectar Biosciences shareholder, owning 1.14M shares representing 3.54% of the company. Austin W. Greenhouse David M. Marxe's Cellectar Biosciences shares are currently valued at $4.15M.

If you're new to stock investing, here's how to buy Cellectar Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.